Tumor weight, also recorded at sacrifice 7 weeks after SW620 cell injection, was significantly lower (p < 0.05) in sestrin 2-overexpressing xenografts compared with negative controls (Figure 6D). The gene discussed is SESN2; the disease is neoplasm.